These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26212261)

  • 1. Impairment of Liver Glycogen Storage in the db/db Animal Model of Type 2 Diabetes: A Potential Target for Future Therapeutics?
    Sullivan MA; Harcourt BE; Xu P; Forbes JM; Gilbert RG
    Curr Drug Targets; 2015; 16(10):1088-93. PubMed ID: 26212261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in hepatic glycogen metabolism in the genetically diabetic (db/db) mouse.
    Roesler WJ; Khandelwal RL
    Diabetes; 1985 Apr; 34(4):395-402. PubMed ID: 2982686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glycogen metabolism in the db/db mouse.
    Roesler WJ; Pugazhenthi S; Khandelwal RL
    Mol Cell Biochem; 1990 Feb; 92(2):99-106. PubMed ID: 2407941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular structural differences between type-2-diabetic and healthy glycogen.
    Sullivan MA; Li J; Li C; Vilaplana F; Stapleton D; Gray-Weale AA; Bowen S; Zheng L; Gilbert RG
    Biomacromolecules; 2011 Jun; 12(6):1983-6. PubMed ID: 21591708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrations in the diurnal rhythms of plasma glucose, plasma insulin, liver glycogen, and hepatic glycogen synthase and phosphorylase activities in genetically diabetic (db/db) mice.
    Roesler WJ; Helgason C; Gulka M; Khandelwal RL
    Horm Metab Res; 1985 Nov; 17(11):572-5. PubMed ID: 3935557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and Berberine suppress glycogenolysis by inhibiting glycogen phosphorylase and stabilizing the molecular structure of glycogen in db/db mice.
    Liu X; Wang K; Zhou J; Sullivan MA; Liu Y; Gilbert RG; Deng B
    Carbohydr Polym; 2020 Sep; 243():116435. PubMed ID: 32532388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasting on liver glycogen structure in rats with type 2 diabetes.
    Wang L; Liu Q; Wang M; Du Y; Tan X; Xu B; Cheung U; Li E; Gilbert RG; Tang D
    Carbohydr Polym; 2020 Jun; 237():116144. PubMed ID: 32241436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models.
    Furukawa S; Murakami K; Nishikawa M; Nakayama O; Hino M
    J Antibiot (Tokyo); 2005 Aug; 58(8):503-6. PubMed ID: 16266121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise training does not correct abnormal cardiac glycogen accumulation in the db/db mouse model of type 2 diabetes.
    Shearer J; Ross KD; Hughey CC; Johnsen VL; Hittel DS; Severson DL
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E31-9. PubMed ID: 21386062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fragility of liver glycogen from humans with type 2 diabetes: A pilot study.
    Wang Z; Min X; Hu Z; Sullivan MA; Tang Y; Wang L; Gilbert RG; Shi C; Deng B
    Int J Biol Macromol; 2022 Nov; 221():83-90. PubMed ID: 36075306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular structure of glycogen in diabetic liver.
    Deng B; Sullivan MA; Li J; Tan X; Zhu C; Schulz BL; Gilbert RG
    Glycoconj J; 2015 May; 32(3-4):113-8. PubMed ID: 25796617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal changes of glycogen molecular structure in healthy and diabetic mice.
    Hu Z; Deng B; Tan X; Gan H; Li C; Nada SS; Sullivan MA; Li J; Jiang X; Li E; Gilbert RG
    Carbohydr Polym; 2018 Apr; 185():145-152. PubMed ID: 29421051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic overexpression of protein targeting to glycogen attenuates obesity and improves hyperglycemia in db/db mice.
    López-Soldado I; Guinovart JJ; Duran J
    Front Endocrinol (Lausanne); 2022; 13():969924. PubMed ID: 36157460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of degradation of liver glycogen phosphorylase is specifically decreased in the C57BL/KsJ-db/db mouse.
    Roesler WJ; Nijjar MS; Khandelwal RL
    Mol Cell Biochem; 1989 Jun; 87(2):147-52. PubMed ID: 2770718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glycogen structure over feeding cycle sheds new light on blood-glucose control.
    Sullivan MA; Aroney ST; Li S; Warren FJ; Joo JS; Mak KS; Stapleton DI; Bell-Anderson KS; Gilbert RG
    Biomacromolecules; 2014 Feb; 15(2):660-5. PubMed ID: 24372590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in a rat model of non-insulin-dependent diabetes.
    Kruszynska YT; Home PD
    Diabetologia; 1988 May; 31(5):304-9. PubMed ID: 3135217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen structure in type 1 diabetic mice: Towards understanding the origin of diabetic glycogen molecular fragility.
    Hu Z; Li E; Sullivan MA; Tan X; Deng B; Gilbert RG; Li C
    Int J Biol Macromol; 2019 May; 128():665-672. PubMed ID: 30708007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic properties of glycogen synthase and phosphorylase and structural aspects of glycogen in the db/db mouse liver.
    Roesler WJ; Khandelwal RL
    Diabetes; 1986 Feb; 35(2):210-6. PubMed ID: 3080350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Structure of Human-Liver Glycogen.
    Deng B; Sullivan MA; Chen C; Li J; Powell PO; Hu Z; Gilbert RG
    PLoS One; 2016; 11(3):e0150540. PubMed ID: 26934359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.